What does CUSIP 14740B901 represent in this 13F holders report?

CUSIP 14740B901 is the security identifier for 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call used to aggregate holder disclosures.

How many institutions held 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call in Q3 2016?

No institutional holders were reported for 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call in Q3 2016; review adjacent reporting periods for trend context.

CASCADIAN THERAPEUTICS INC - COM - Call

CUSIP: 14740B901

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class: Equity / COM
Price per share: $6.70
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 14740B901?
CUSIP 14740B901 identifies 14740B901 - CASCADIAN THERAPEUTICS INC - COM - Call in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2016
Previous quarter: Q2 2016

Recent filing periods for CUSIP 14740B901:

Q1 2017 Q4 2016 Q3 2016 Q2 2016

CASCADIAN THERAPEUTICS INC - COM - Call

Q3 2016 13F Holders as of 30 Sep 2016

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CASCADIAN THERAPEUTICS INC - COM - Call as of Q3 2016.